NRP1 and glioblastoma: NRP1 was found to be a risk factor in different cancers, including ACC (HR 1.027, 95% CI 1.014-1.040, p < 0.001), CESC (HR 1.021, 95% CI 1.007-1.035, p < 0.003), GBM (HR 1.014, 95% CI 1.004-1.025, p = 0.009), LGG (HR 1.038, 95% CI 1.024-1.053, p < 0.0001), LIHC (HR 1.009, 95% CI 1.003-1.016, p = 0.0053), MESO (HR 1.011, 95% CI 1.003-1.020, p = 0.0062), and STAD (HR 1.018, 95% CI 1.010-1.026, p < 0.0001) (Figure 3(a)).